Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients.
Paraskevi C FragkouLina PalaiodimouMaria-Ioanna StefanouAristeidis H KatsanosVaia LambadiariDimitrios ParaskevisElisabeth AndreadouDimitra DimopoulouChristina ZompolaPanagiotis FerentinosTheodoros I VassilakopoulosAnastasia KotanidouPetros P SfikakisSotirios TsiodrasGeorgios K TsivgoulisPublished in: Therapeutic advances in neurological disorders (2022)
The study protocol has been registered in the International Prospective Register of Ongoing Systematic Reviews PROSPERO (Registration number: CRD42021229771).